Tag: life sciences
-
Trial Shows Malaria Vaccine Protects Young Children
Results from a clinical trial in Burkina Faso show a high efficacy rate for a candidate vaccine to protect young children against malaria infections.
-
Biomanufacturing Materials Company Issues $500M IPO
Zymergen Inc., a developer of materials made with synthetic biology for industrial products is raising $500 million in its initial public stock offering.
-
Trials Adding Covid-19 Hospital, Out-Patient Therapies
National Institutes of Health is adding a new treatment to a clinical trial for Covid-19 patients hospitalized with severe respiratory failure.
-
Microbiome Health Company Raises $40M in Early Funds
A developer of therapies and health products addressing microbes inhabiting the human body is raising $40 million in its first venture funding round.
-
Small Biz Award Funds Home Elder Muscle Device
A start-up company spun-off from Dartmouth College received a grant to develop a device for older people to measure their muscle mass exercises at home.
-
Start-Up Designing Synthetic DNA for Gene Therapies
A new biotechnology company is underway creating gene therapies for inherited diseases delivered with synthetic DNA instead of benign viruses.
-
Challenge Trial Testing Covid-19 Reinfection
A clinical trial is underway testing immune responses from new Covid-19 infections in volunteers previously infected with the virus.
-
AI Drug Discovery Company Acquired in $270M Deal
A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery company based on machine learning algorithms.
-
Lilly Asks FDA to Revoke Covid-19 Therapy Clearance
Drug maker Eli Lilly and Co. asked the Food and Drug Administration to revoke its authorization for bamlanivimab alone to treat for Covid-19 infections.
-
Novavax Joins Alternative Second Shot Vaccine Trial
Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in first and second immunizations.